Homeopathy 2016; 105(03): 265-269
DOI: 10.1016/j.homp.2016.04.003
Original Paper
Copyright © The Faculty of Homeopathy 2016

In vitro assessment of anticytotoxic and antigenotoxic effects of CANOVA®

Authors

  • Henrique Fonseca Sousa do Nascimento

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • Plínio Cerqueira dos Santos Cardoso

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • Helem Ferreira Ribeiro

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • Tatiane Cristina Mota

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • Lorena Monteiro Gomes

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • André Salim Khayat

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • Adriana Costa Guimarães

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • Marucia Irena Medeiros Amorim

    2   Universidade da Amazônia (UNAMA), Belém, Pará, Brazil
  • Rommel Rodriguéz Burbano

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
  • Marcelo de Oliveira Bahia

    1   Laboratório de Citogenética Humana, Instituto de Ciências Biológicas, Universidade Federal do Pará (UFPA), Belém, Pará, Brazil
Weitere Informationen

Publikationsverlauf

Received08. April 2015
revised20. Februar 2016

accepted29. Februar 2016

Publikationsdatum:
28. Dezember 2017 (online)

Preview

Background: CANOVA® (CA) is a homeopathic immunomodulator. It contains several homeopathic medicines prepares according to the Brazilian Pharmacopoeia. CA is indicated in clinical conditions in which the immune system is impaired and against tumors. N-methyl-N-nitrosourea (NMU) is an N-nitroso compound, with genotoxic/mutagenic properties. Although several studies have shown promising results in the use of CA, there are no studies reporting possible antigenotoxic effects.

Method: This study evaluated the in vitro antigenotoxic and anticytotoxic effects of CA in human lymphocytes exposed to NMU. Samples of human lymphocytes that were subjected to different concentrations of a mixture containing CA and NMU were used. The genotoxicity/antigenotoxicity of CA was evaluated by the comet assay, anticytotoxicity was assessed by quantification of apoptosis and necrosis using acridine orange/ethidium bromide.

Results: CA significantly reduced DNA damage induced by NMU and reduced significantly the frequency of NMU-induced apoptosis after 24 h of treatment.

Conclusion: CA has an important cytoprotective effect significantly reducing the DNA damage and apoptosis induced by the carcinogen NMU.